DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» GSK3A
GSK3A
Comprehensive Assessment of Indian Variations in the Druggable Kinome Landscape Highlights Distinct Insights at the Sequence, Structure and Pharmacogenomic Stratum
Glycogen Synthase Kinase-3 Inhibition Induces Glioma Cell Death Through C-MYC, Nuclear Factor-KB, and Glucose Regulation
GSK3 and Its Interactions with the PI3K/AKT/Mtor Signalling Network
Supplementary Table 2
Serine-Threonine Kinases and Transcription Factors Active in Signal
Activation of Diverse Signalling Pathways by Oncogenic PIK3CA Mutations
Human Kinases Info Page
Global Phosphoproteomic Profiling Reveals Perturbed Signaling in a Mouse Model of Dilated Cardiomyopathy
Anti-Gsk3a (GW22778)
Downloads.Action)
Epigenetic Modulation in BRAF Mutated Metastatic Colorectal Cancer
Akt/PKB Kinase Phosphorylates Separately Thr212 and Ser214 of Tau Protein in Vitro
Porcine Sperm Motility Is Regulated by Serine Phosphorylation of the Glycogen Synthase Kinase-3A
Isoform- and Cell Type–Specific Roles of Glycogen Synthase Kinase 3 N
Supporting Information
MAPK Pathway and B Cells Overactivation in Multiple Sclerosis Revealed by Phosphoproteomics and Genomic Analysis
In Vitro and in Vivo Antitumor and Anti-Inflammatory Capabilities of the Novel GSK3 and CDK9 Inhibitor ABC1183 S
CG0009, a Novel Glycogen Synthase Kinase 3 Inhibitor, Induces Cell Death Through Cyclin D1 Depletion in Breast Cancer Cells
Top View
Supplementary Material Identification of Motility-Associated Progesterone
Kinome Expression Profiling to Target New Therapeutic Avenues in Multiple Myeloma
Targeting GSK3 and Associated Signaling Pathways Involved in Cancer
GSK3: an Important Paralog in Neurodegenerative Disorders And
Nanostring®: Product Data Sheet | Ncounter® GX Human Kinase
INHIBITORS of CYCLIN-DEPENDENT KINASES AS CANCER THERAPEUTICS Authors
Human Phospho-MAPK Array Kit
A. Supplementary Figure 1
A Resource for Exploring the Understudied Human Kinome for Research and Therapeutic
Mtor Signaling, Function, Novel Inhibitors, and Therapeutic Targets
Wnt/Β-Catenin Pathway Activation Mediates Adaptive Resistance to BRAF Inhibition in Colorectal Cancer
Labchip|Profilerpro
Supplemental Information Revision
MAP Kinase Phosphatase 3 (MKP-3) Deficient Mice Are Resistant to Diet Induced-Obesity
A New Alpha in Line Between KRAS and NF-Kb Activation?
A Protein Kinase A–Independent Pathway Controlling
Systemic Toxicity Reported for CDK8/19 Inhibitors CCT251921 and MSC2530818 Is Not Due to Target Inhibition
A Screen for Transcription Factor Targets of Glycogen Synthase Kinase-3 Highlights an Inverse Correlation of Nfκb and Androgen Receptor Signaling in Prostate Cancer